Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04634110
Title Brigatinib Before Brain Irradiation Trial (B3i Trial)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Colorado, Denver
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST